Current Cancer Drug Targets
Title:Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy)
Volume: 16 Issue: 8
Author(s): Maria Bozko, Monika Podhorecka, Arkadiusz Macheta, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko
Affiliation:
Export Options
About this article
Cite this article as:
Bozko Maria, Podhorecka Monika, Macheta Arkadiusz, Bozko Andrzej, Malek P. Nisar and Bozko Przemyslaw, Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy), Current Cancer Drug Targets 2016; 16 (8) . https://dx.doi.org/10.2174/156800961608160902101746
DOI https://dx.doi.org/10.2174/156800961608160902101746 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Low Molecular Weight Heparins and Fondaparinux Upon Thrombin Generation Triggered by Human Pancreatic Cancer Cells BXPC3
Current Vascular Pharmacology Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer
Current Medicinal Chemistry Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology Comparison of Ultrasonography and Computed Tomography Features of Calcified Thyroid Nodules
Current Medical Imaging Synthesis and In vitro/In vivo Characterization of Raloxifene Grafted Poly(Styrene Maleic Acid)-Poly(Amide-Ether-Ester-Imide) Micelles for Targeted Delivery of Docetaxel in G Protein-Coupled Estrogen Receptor Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators
Current Topics in Medicinal Chemistry MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications
Current Molecular Medicine Recent Advances in Structural Studies of the Carbonic Anhydrase Family: The Crystal Structure of Human CA IX and CA XIII
Current Pharmaceutical Design Global View on Rare Diseases: A Mini Review
Current Medicinal Chemistry Editorial (Thematic Issue: Novel Therapeutic Strategies for Castration-resistant Prostate Cancer: Update and Future Perspectives)
Clinical Cancer Drugs Pharmacogenetics of the Human MDR1 Multidrug Transporter
Current Pharmacogenomics Editorial [Hot Topic: Molecular Mechanisms and Therapeutic Reversal of Immune Suppression in Cancer (Guest Editor: Dmitry I. Gabrilovich)]
Current Cancer Drug Targets Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer
Current Bioactive Compounds Resveratrol and Its Analogues: Promising Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry SUBJECT INDEX TO VOLUME 1
Current Drug Targets VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Sculpted Amphiphilic Liposomal Particles for Modifiable Medicinal Applications
Current Drug Discovery Technologies Inflammatory Aspects of Depression
Inflammation & Allergy - Drug Targets (Discontinued) An Update on Clinical Drug Interactions with the Herbal Antidepressant St. Johns wort
Current Drug Metabolism ATP-Competitive Inhibitors of mTOR: An Update
Current Medicinal Chemistry